February 2023 - SentryX Strengthens Clinical Operations Team
Back to overview
SentryX welcomes Lin Roest as the newest member of its clinical operations team. With over 14 years of experience in clinical research, Lin will be of great value as the company completes the observational study, carries out a Phase Ib clinical trial, and prepares for the subsequent confirmatory trial.
After obtaining a master’s degree in Animal Science, Lin worked at Cardialysis, Novo Nordisk, and Julius Clinical before becoming a Clinical Trial Manager at ProQR Therapeutics. Lin started her work at SentryX in February 2023, and we are very happy to have her on board.